| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2021 | Dec 21, 2021 | Eledon Pharmaceuticals, Inc. | CEO | Buy | 90.0 | +2,000 | 28.57% | ✗ | $9K |
| Aug 17, 2021 | Aug 19, 2021 | Eledon Pharmaceuticals, Inc. | CEO | Buy | 91.3 | +4,000 | 133.33% | ✗ | $24.8K |
| Jun 9, 2021 | Jun 10, 2021 | Eledon Pharmaceuticals, Inc. | CEO | Buy | 91.3 | +3,000 | 100.00% | ✗ | $24K |
| Feb 22, 2016 | Feb 24, 2016 | ALNYLAM PHARMACEUTICALS, INC. | SVP, Chief Business Officer | Buy | 95.0 | +1,000 | 100.00% | ✗ | $62.7K |